Overview

Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This proof-of-concept study examines whether the acute brain dysfunction that occurs in critically ill patients is improved by administration of intravenous guanfacine.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Medical Center
Collaborator:
Massachusetts General Hospital
Treatments:
Guanfacine